Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

8.67
-0.2450-2.75%
Volume:91.82K
Turnover:812.08K
Market Cap:423.60M
PE:-2.70
High:9.03
Open:8.89
Low:8.65
Close:8.91
52wk High:14.53
52wk Low:2.22
Shares:48.89M
Float Shares:19.14M
Volume Ratio:0.88
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.22
PE(LYR):-2.53

Loading ...

Artiva Biotherapeutics price target raised to $35 from $15 at H.C. Wainwright

TIPRANKS
·
May 09

Artiva Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 09

BUZZ-U.S. STOCKS ON THE MOVE-Corning, Moderna, News Corp

Reuters
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Coinbase, Microchip, Wendy's

Reuters
·
May 08

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

MT Newswires Live
·
May 08

Wedbush Adjusts Price Target on Artiva Biotherapeutics to $40 From $23, Maintains Outperform Rating

MT Newswires Live
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Cloudflare, IREN, Monster Beverage

Reuters
·
May 08

Artiva Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Top Premarket Gainers

MT Newswires Live
·
May 08

Artiva Biotherapeutics Prices $300 Million Shares, Warrants Offering

MT Newswires Live
·
May 08

Artiva Biotherapeutics Posts Positive Early Data for AlloNK Rheumatoid Arthritis Treatment

MT Newswires Live
·
May 08

Artiva Biotherapeutics reports Q1 EPS (95c), consensus (84c)

TIPRANKS
·
May 08

Artiva Biotherapeutics prices USD 300 million follow-on equity offering at USD 11.52/share

Reuters
·
May 08

Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
May 08

Artiva Biotherapeutics Inc - Prices Offering of 23.9 Mln Shares at $11.52 per Share and 2.2 Mln Pre-Funded Warrants at $11.5199 per Share

THOMSON REUTERS
·
May 08

BUZZ-Artiva jumps as cell therapy shows benefits in rheumatoid arthritis

Reuters
·
May 08

Artiva Biotherapeutics Inc - Suspends Offering of Common Stock Under Sales Agreement With Leerink Partners - SEC Filing

THOMSON REUTERS
·
May 08

Artiva Biotherapeutics Q1 EPS $(0.95) Misses $(0.89) Estimate

Benzinga Earnings
·
May 08

Artiva Biotherapeutics Inc - Cash, Cash Equivalents and Investments $86.8 Mln as of March 31, 2026; Funds Operations Into Q2 2027

THOMSON REUTERS
·
May 08

Artiva Biotherapeutics Inc Qtrly EPS $-0.95

THOMSON REUTERS
·
May 08